Perception Neuroscience
Developer of arketamine therapy intended to provide effective treatment solutions to serious psychiatric disorders.The company's lead product is the NMDA antagonist arketamine with the potential for rapid acting antidepressant activity and anti-suicidal effects.
Acquisition Transaction
Acquired Company
Company Operating Status
Active
Crunchbase URL
Facebook URL
Founded Date
2018
0
Full Address
180 Varick Street, Suite 637
New York, NY 10014
Investors
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
0
Parent Organization
Pitchbook URL
Official Website
Find more companies like Perception Neuroscience
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.